4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-045698
Chief Financial Officer acquired 91,180 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2024-04-16 | Grant or award | +91,180 | 225,964 | D | ||
| Derivatives | |||||||
| FRATES JAMES M Chief Financial Officer | 2024-04-16 | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | D | ||
Loading xslF345X05/ownership.xml…